Monte Rosa Therapeutics, Inc. (GLUE) stock
GLUENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3038% above fair value
$8.91−0.16 (-1.76%)
Close on Nov 19, 2026Market cap $760.14MP/E –Yield –
Monte Rosa Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Monte Rosa Therapeutics's market cap was $878.68M on Nov 11, 2026, against $999.15M a year earlier. Over the last 5 years it ranged from $155.20M to $2.04B, with a median of $381.41M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $878.68M | -9.3% |
| 2025 | Dec 31, 2025 | $968.87M | +127.5% |
| 2024 | Dec 31, 2024 | $425.96M | +50.6% |
| 2023 | Dec 29, 2023 | $282.87M | -23.2% |
| 2022 | Dec 30, 2022 | $368.12M | -61.2% |
| 2021 | Dec 31, 2021 | $949.20M | – |
See a number that looks wrong?